MLNAX
Price
$23.15
Change
-$0.64 (-2.69%)
Updated
Dec 18 closing price
RPEBX
Price
$63.82
Change
-$2.03 (-3.08%)
Updated
Dec 18 closing price
Ad is loading...

MLNAX vs RPEBX

Header iconMLNAX vs RPEBX Comparison
Open Charts MLNAX vs RPEBXBanner chart's image
Morgan Stanley Instl Glbl Concntr A
Price$23.15
Change-$0.64 (-2.69%)
VolumeN/A
CapitalizationN/A
American Funds New Perspective R2E
Price$63.82
Change-$2.03 (-3.08%)
VolumeN/A
CapitalizationN/A
MLNAX vs RPEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MLNAX vs. RPEBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLNAX is a Hold and RPEBX is a Buy.

FUNDAMENTALS
Fundamentals
RPEBX has more cash in the bank: 149B vs. MLNAX (230M). RPEBX (0.46) and MLNAX (0.44) have matching dividends . MLNAX was incepted earlier than RPEBX: MLNAX (9 years) vs RPEBX (10 years). MLNAX is a more actively managed with annual turnover of: 51.00 vs. RPEBX (17.00). RPEBX has a lower initial minimum investment than MLNAX: RPEBX (250) vs MLNAX (1000). MLNAX annual gain was more profitable for investors over the last year : 36.33 vs. RPEBX (21.61). MLNAX return over 5 years is better than : 74.85 vs. RPEBX (42.95).
MLNAXRPEBXMLNAX / RPEBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years10 years-
Gain YTD36.17620.981172%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets230M149B0%
Annual Yield % from dividends0.440.4697%
Returns for 1 year36.3321.61168%
Returns for 3 years28.816.18466%
Returns for 5 years74.8542.95174%
Returns for 10 yearsN/A71.21-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMY57.651.78
+3.19%
Bristol-Myers Squibb Co
TNET90.91-0.62
-0.68%
Trinet Group
SOUN19.39-0.30
-1.52%
SoundHound AI
FARO27.60-0.59
-2.09%
FARO Technologies
VRCA0.70-0.02
-2.51%
Verrica Pharmaceuticals